Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical - 6-MTH group results

Aug 8 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             73.63               71.26           172.00    
                 (+3.3 pct)          (+6.3 pct)       (+3.5 pct)  
  Operating         10.41                9.87            25.50    
                 (+5.5 pct)          (-3.6 pct)       (-4.4 pct)  
  Recurring         11.17               10.90            26.50    
                 (+2.5 pct)          (-1.7 pct)       (-6.3 pct)  
  Net                7.86                7.70            20.20    
                 (+2.1 pct)          (-2.3 pct)       (+0.9 pct)  
  EPS            103.35 yen           99.55 yen       265.74 yen  
  Ann Div                             90.00 yen        96.00 yen  
  -Q2 div         43.00 yen           38.00 yen                   
  -Q4 div                             52.00 yen        53.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news